Karen Liu
Karen Liu

Dr. Karen Liu has been active in China healthcare venture investment since 2005. She is a founding partner of 3E Bioventures Capital, a healthcare-focused venture investment firm actively investing in worldwide new drugs and innovative medical devices and diagnostics.
Prior to 3E Bioventures, Dr. Karen Liu was a partner of Kaiwu Capital and Managing Director at CRCI Capital, in charge of healthcare investment.
Dr. Karen Liu received her Ph.D. in Immunology and Master of Medical Sciences degree from Harvard University, and Bachelor of Sciences degree from Cornell University. She also received an EMBA degree from CKGSB-Chungkong Graduate School of Business in China.